99% Purity IGF-1 LR3 Synthetic Peptide for Laboratory Research Application
3 Inquiries
143045-27-6
Research Grade
99%
HK
HNYH
1mg/vial, 10 vials/box
2026-06-25
Retatrutide
-
Product Description
-
Seller Information
-
Inquiry History
-
DescriptionResearch & Reference Note
99% Purity IGF-1 LR3 Synthetic Peptide for Laboratory Research Application is listed on ECHEMI for industrial / laboratory sourcing. This listing is for industrial and laboratory research use. Product information on ECHEMI is provided for sourcing and specification reference. It is not medical advice, a clinical recommendation, or an approved therapy description. Always verify regulatory status, purity, and intended use with the supplier and applicable authorities before purchase or use.
Authoritative sourcesDisclaimer: This listing is for industrial and laboratory research use. Product information on ECHEMI is provided for sourcing and specification reference. It is not medical advice, a clinical recommendation, or an approved therapy description. Always verify regulatory status, purity, and intended use with the supplier and applicable authorities before purchase or use.
Reviewed by ECHEMI Scientific Review - Platform editorial review for research chemicals
Basic Info-
Product Name:
LONG R3 IGF-I RECOMBINANT ANALOG
Other Name:LONG R3 IGF-I RECOMBINANT ANALOG;long R3 igf-I;LONGR3IGF-I MEDIA GRADE;LONG? R3 IGF-I human;rh-IGF-1;LONG R3 IGF-1 (human)
CAS No.:143045-27-6
Molecular Weight:0
Categories:
Characteristics-
Critical Temperature & Pressure:
2-8°C
-
-
Seller Information
-
Business Type:
Trader
-
Main Products:
Retatrutide
-
Location:
Lobby of Area B, Area E, Area F and Area G (Central Office Area), Landao Research Center, No.3 Yingbin Road, Yangpu Economic Development Zone, Hainan Province
-
Payment Terms:
TT against copy of documents,D/P
-
Average lead Time:
3 days
-
Total Annual Revenue:
$2.5 million-$5 million
-
Total Employees:
51-100
-
Year of Establishment:
2025
Company Certificates-
Retatrutide
-
Retatrutide
-
Retatrutide
-
Retatrutide
-
-
Inquiry History3 Inquiries
Country Product Purchase Quantity Date Posted
Russia
IGF1-LR3
200 G Sep 25, 2026
United States
igf1 lr3
1 G Jun 4, 2026
Australia
IGF-lr3
100 Dec 22, 2023 Post an enquiry for this product
More from this Seller
-
-
-
99% Purity MOTS-c Synthetic Peptide for Laboratory Research Applications
Research Grade / 99%
-
-
-
-
99.9% High Purity Selank Peptide Powder CAS 129954-34-3 Research Grade Raw Material
Pharmaceutical Grade / 99.9%
-